换一批
换一批Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
作者：
主题词
成年人(Adult);阿扎胞苷(Azacitidine);染色质组装和分解(Chromatin Assembly and Disassembly);染色体倒位(Chromosome Inversion);染色体, 人, 16对(Chromosomes, Human, Pair 16);染色体, 人, 21对(Chromosomes, Human, Pair 21);染色体, 人, 8对(Chromosomes, Human, Pair 8);核心结合因子α2亚基(Core Binding Factor Alpha 2 Subunit);DNA甲基化(DNA Methylation);DNA修饰甲基酶类(DNA Modification Methylases);酶抑制剂(Enzyme Inhibitors);后成说, 遗传(Epigenesis, Genetic);基因表达谱(Gene Expression Profiling);基因表达调控, 白血病(Gene Expression Regulation, Leukemic);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);人类(Humans);羟肟酸类(Hydroxamic Acids);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);突变(Mutation);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);启动区, 遗传(Promoter Regions, Genetic);RNA, 信使(RNA, Messenger);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);易位, 遗传(Translocation, Genetic);肿瘤细胞, 培养的(Tumor Cells, Cultured);U937细胞(U937 Cells)
DOI
10.1016/j.leukres.2007.11.038
PMID
18206229
发布时间
2018-12-01
- 浏览15
Leukemia research
944-53页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
